Therefore, IL23R is a more important genetic modifier of IBD susceptibility than IL12B, suggesting a more important pathogenic role of Th17 cells, which express IL-23R, than Th1 cells, which develop under the control of IL-12. The gene discussed is IL23R; the disease is inflammatory bowel disease.